Health care contingent valuation studies: A review and classification of the literature

Health Economics

Volumn 7, Issue 4, 1998, Pages 313-326

  Diener, Alan ^a   O'Brien, Bernie ^a,b   Gafni, Amiram ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b CENTRE FOR EVALUATION OF MEDICINES   (Canada)

Author keywords

Contingent valuation method; Cost benefit analysis; Health care

Indexed keywords

ARTICLE; CONSUMER; COST BENEFIT ANALYSIS; DATA BASE; HEALTH CARE COST; HEALTH CARE QUALITY; INTERVIEW; PRIORITY JOURNAL;

ATTITUDE TO HEALTH; BIBLIOMETRICS; CONSUMER SATISFACTION; COST-BENEFIT ANALYSIS; DATABASES; HEALTH CARE SURVEYS; HEALTH SERVICES NEEDS AND DEMAND; HEALTH SERVICES RESEARCH; QUESTIONNAIRES; SOCIAL VALUES;

EID: 0031855391     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1050(199806)7:4<313::AID-HEC350>3.0.CO;2-B     Document Type: Article

References (61)

1. Johannesson, M. The contingent valuation method - appraising the appraisers. Health Economics 1993; 2: 357-9.
2. Mishan, E.J. Cost-benefit analysis. London: Allen and Unwin, 1971.
3. Gafni, A. Willingness-to-pay as a measure of benefits. Relevant questions in the context of public decision making about health care programs. Medical Care 1991; 29: 1246-52.
4. Mitchell, R.C. and Carson, R.T. Using surveys to value public goods: the contingent valuation method. Washington, D.C.: Resources for the Future, 1989.
5. Jones-Lee, M.W., Hammerton, M. and Phillips, P.R. The value of safety: results of a national sample survey. Economic Journal 1985; 95: 49-72.
6. Johannesson, M., Johansson, P.-O., Kristrom, B. and Gerdtham, U.-G. Willingness to pay for antihypertensive therapy: further results. Journal of Health Economics 1993; 12: 95-108.
7. Johannesson, M. and Jonsson, B. Willingness to pay for antihypertensive therapy: results of a Swedish pilot study. Journal of Health Economics 1991: 10: 461-74.
8. Johannesson, M. Economic evaluation of hypertension treatment. International Journal of Technology Assessment in Health Care 1992; 8: 506-23.
9. Neumann, P.J. and Johannesson, M. The willingness to pay for in vitro fertilization: a pilot study using contingent valuation. Medical Care 1994; 32: 686-99.
10. Miedzybrodzka, Z., Semper, J., Shackley, P., Abdalla, M. and Donaldson, C. Stepwise or couple antenatal carrier screening for cystic fibrosis? Women's preferences and willingness to pay. Journal of Medical Genetics 1995; 32: 282-3.
11. Miedzybrodzka, Z., Shackley, P., Donaldson, C. and Abdalla, M. Counting the benefits of a screening: a pilot study of willingness to pay for cystic fibrosis carrier screening. Journal of Medical Screening 1994; 1: 82-3.
12. Donaldson, C., Shackley, P., Abdalla, M. and Miedzybrodzka, Z. Willingness to pay for antenatal carrier screening for cystic fibrosis. Health Economics 1995; 4: 439-52.
13. O'Brien, B., Novosel, S., Torrance, G. and Streiner, D. Assessing the economic value of a new antidepressant. PharmacoEconomics 1995; 8: 34-45.
14. Morrison, G.C. and Gyldmark, M. Appraising the use of contingent valuation. Health Economics 1992; 1: 233-43.
15. O'Brien, B. and Gafni, A. When do the dollars make sense? Toward a conceptual framework for contingent valuation studies in health care. Medical Decision Making 1996; 16: 288-99.
16. Carson, R.T., Wright, J., Carson, N., Alberini, A. and Flores, N. A bibliography of contingent valuation studies and papers. La Jolla, CA: National Resource Damage Assessment, 1995.
17. Thompson, M.S., Read, J.L. and Liang, M. Feasibility of willingness-to-pay measurement in chronic arthritis. Medical Decision Making 1984; 4: 195-215.
18. Reardon, G. and Pathak, D.S. Segmenting the antihistamine market: an investigation of consumer references. Journal of Health Care Marketing 1990; 10: 23-33.
19. Hill, J.W. Valuing reductions in risk of breast cancer mortality: A comparison of revealed preference and contingent valuation methods. PhD Dissertation. Madison: University of Wisconsin, 1988.
20. Johannesson, M., Johansson, P.-O., Kristrom, B., Borgquist, L. and Jonsson, B. Willingness to pay for lipid lowering: a health production function approach. Applied Economics 1993; 25: 1023-31.
21. Donaldson, C., Thomas, R. and Torgerson, D.J. Validity of open-ended versus payment scale approaches to eliciting willingness to pay. Applied Economics 1996; 29: 79-84.
22. Donaldson, C., Hundley, V. and Mapp, T. Willingness to pay: a new method for measuring patients' preferences? HERU Discussion Paper 03195. Aberdeen: Health Economics Research Unit, University of Aberdeen, 1995.
23. Donaldson, C. Willingness to pay for publicly-provided goods: a possible measure of benefit? Journal of Health Economics 1990; 9: 103-18.
24. Olsen, J.A. and Donaldson, C. Willingness to pay for public sector health care programmes in northern Norway. HERU Discussion Paper 05/93. Aberdeen: Health Economics Research Unit, University of Aberdeen, 1993.
25. O'Conor, R.M. and Bloomquist, G.C. Measurement of consumer-patient preferences using a hybrid contingent valuation method. Stockholm: Centre for Health Economics, School of Economics, 1996.
26. Blomquist, G.C. and O'Conor, R.M. Eliciting preference for safety and efficacy of asthma treatments from nonasthmatic individuals. Kentucky: Department of Economics, University of Kentucky, 1996.
27. Stalhammar, N.-O. An empirical note on willingness to pay and starting point bias. Medical Decision Making 1996; 16: 247.
28. O'Brien,. B. and Viramontes, J.L. Willingness to pay: a valid and reliable measure of health state preference? Medical Decision Making 1993; 14: 289-97.
29. Kartman, B., Andersson, F. and Johannesson, M. Willingness to pay for reductions in angina pectoris attacks. Medical Decision Making 1996; 16: 248-53.
30. Thompson, M.S. Willingness to pay and accept risks to cure chronic disease. American Journal of Public Health 1986; 76: 392-6.
31. O'Brien, B., Goeree, R., Gafni, A., Torrance, G.W. et al. Assessing the value of a new pharmaceutical: a feasibility study of contingent valuation in managed care. Medical Care 1998; forthcoming.
32. Nathan, R.G., Bont, G.M. and Minz, R.B. Patient interest in receiving audiotapes of information presented by their physicians. A survey of patients awaiting treatment in university and private practice settings. Archives of Family Medicine 1994; 3: 509-13.
33. Gore, P.R. and Madhavan, S. Consumers' preference and willingness to pay for pharmacist counselling for non-prescription medicines. Journal of Clinical Pharmacy and Therapeutics 1994; 19: 17-25.
34. Einarson, T.R., Bootman, J.L., McGhan, W.F., Larson, L.N., Gardner, M.E. and Donohue, M. Establishment and evaluation of a serum cholesterol monitoring service in a community pharmacy. Drug Intelligence and Clinical Pharmacy 1988; 22: 45-8.
35. Fisher, M., Marks, A., Trieller, K. and Brody, R. Are adolescents able and willing to pay the fee for confidential health care? Journal of Pediatrics 1985; 107: 480-3.
36. Johannesson, M. and Fagerberg, B. A health economic comparison of diet and drug treatment in obese men with mild hypertension. Journal of Hypertension 1992; 10: 1063-70.
37. Culbertson, V.L., Arthur, T.G., Rhodes, P.J. and Rhodes, R.S. Consumer preferences for verbal and written medication information. Drug Intelligence and Clinical Pharmacy 1988; 22: 390-6.
38. Ellison, P. and Marr, J. Willingness to pay for unfunded health services in a family practice clinic. Leadership in Health Services 1994; 3: 14-7.
39. Granberg, M., Wikland, M., Nilsson, L. and Hamberger, L. Couples' willingness to pay for IVF/ET. Acta Obstetrica et Gynaecologica Scandinavica 1995; 74: 17-25.
40. Grimes, D. Value of a negative cervical smear. British Medical Journal 1988; 296: 1636.
41. Pennie, R.A., O'Connor, A.M., Garvock, M.J. and Drake, E.R. Factors influencing the acceptance of hepatitis B vaccine by students in health disciplines in Ottawa. Canadian Journal of Public Health 1991; 82: 12-5.
42. Ryan, M., Ratcliffe, J. and Tucker, J. Using willingness to pay to value alternative models of antenatal care. Social Science and Medicine 1997; 44: 371-80.
43. Eastaugh, S.R. Valuation of the benefits of risk-free blood. Willingness to pay for hemoglobin solutions [Review]. International Journal of Technology Assessment in Health Care 1991; 7: 51-7.
44. Appel, L.J. Risk reduction from low osmolality contrast media: what do patients think it is worth? Medical Care 1990; 28: 324-7.
45. Golan, E.H. and Shechter, M. Contingent valuation of supplemental health care in Israel. Medical Decision Making 1993; 13: 302-10.
46. Berwick, D.M. and Weinstein, M.C. What do patients value? Willingness to pay for ultrasound in normal pregnancy. Medical Care 1985; 23: 881-93.
47. Lindholm, L., Rosen, M. and Hellsten, G. Are people willing to pay for a community-based preventive program. International Journal of Technology Assessment in Health Care 1994; 10: 317-24.
48. Reis, J., Sherman, S., Macon, J. and Friedman, B. Care for the underinsured: who should pay? Journal of Nursing Administration 1990; 20:16-20.
49. Osmond, M.H., Klassen, T.P. and Quinn, J.V. Economic comparison of a tissue adhesive and suturing in the repair of pediatric facial lacerations. Journal of Pediatrics 1991; 230: 307-12.
50. Gafni, A. and Feder, A. Willingness to pay in an equitable society: the case of the kibbutz. International Journal of Social Economics 1987; 14: 16-21.
51. Birdsall, N. and Chuhan, P. Willingness to pay for health and water in rural Mali: do WTP questions work? Population Health and Nutrition Department, World Bank, 1987.
52. Chestnut, L.G., Keller, L.R., Lambert, W.E. and Rowe, R.D. Measuring heart patients' willingness to pay for changes in angina symptoms. Medical Decision Making 1996; 16: 65-77.
53. Eckerlund, I., Johannesson, M., Johansson, P.-O., Tambour, M. and Zethreaus, N. Value for money? A contingent valuation study of the optimal size of the Swedish health care budget. Health Policy 1995; 34: 135-43.
54. Phillips, K.A., Homan, R.K., Luft, H.S. et al. Willingness to pay for poison control centers. Journal of Health Economics 1997; 16: 343-57.
55. Johannesson, M. and Johansson, P.-O. To be or not to be, that is the question - an empirical study of the WTP for an increased life expectancy at an advanced age. Journal of Risk and Uncertainty 1996; 13(2): 163-74.
56. Johannesson, M., Aberg, H., Agreus, L., Borgquist, L. and Jonsson, B. Cost-benefit analysis of nonpharmacological treatment of hypertension. Journal of Internal Medicine 1991; 230: 307-12
57. Donaldson, C., Mapp, T., Farrar, S., Walker, A. and Macphee, S. Assessing community values in health care: Is the willingness to pay method feasible. Health Care Analysis 1997; 5: 7-29.
58. Johannesson, M. A note on the relationship between ex-ante and expected willingness to pay for health care. Social Science and Medicine 1996; 42: 305-11.
59. National Oceanic and Atmospheric Administration. Report of the NOAA panel on contingent valuation. Federal Register 1993; 58: 4607-14.
60. Boyle, K.J. and Bishop, R.C. Welfare measurements using contingent valuation; A comparison of techniques. American Journal of Agricultural Economics 1988; 21-8.
61. Johannesson, M. The contingent valuation controversy in environmental economics and its relevance to health services research. Journal of Health Services and Research Policy 1996; 1: 116-7.